Neutral impactCorporate Action

Alivus Life Sciences Limited — Alteration Of Capital and Fund Raising-XBRL

NSE 1 hr ago·29 Oct 2026, 2:43 pm
Alivus Life Sciences

Alivus Life Sciences Limited has informed the Exchange regarding Allotment of Securities

Affected stocks

Neutral1 stock

Alivus Life Sciences

ALIVUS Neutral

₹1,397.40

Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.

Key takeaways

  • Concerns Alivus Life Sciences (ALIVUS).
  • Category: Corporate Action.

Why it matters

A routine update for Alivus Life Sciences. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at NSE.

More Company news

More news

Alphabet shares drop 13.5%, set for biggest 1-day drop in over 20 years: Why is Google parent falling after Q3 results?

Mint · 29 min ago

Alldigi Tech

Alldigi Tech Limited — Change in Management

Alldigi Tech₹810.10▲ 0.00%

NSE · 30 min ago

Company NSE

TATA PROJECTS LIMITED — Statement of deviation/variation in use of Issue proceeds

NSE · 31 min ago

Company NSE

TATA PROJECTS LIMITED — Statement of utilization of issue proceeds

NSE · 32 min ago

Company NSE

TATA PROJECTS LIMITED — Security Cover

NSE · 33 min ago

Company NSE

TATA PROJECTS LIMITED — Disclosure under Regulation 52(4)

NSE · 34 min ago

Company NSE

TATA PROJECTS LIMITED — Financial Results Updates

NSE · 35 min ago

Strides Pharma SCI

Strides Pharma Science Limited — Change in Directors/KMP/SMP/Auditor/RTA

Strides Pharma SCI₹1,097.50▲ 0.00%

NSE · 37 min ago

Company NSE

TATA PROJECTS LIMITED — Disclosure under Regulation 23(9)

NSE · 37 min ago

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.